source Post navigation Deal Boosts Gene-Editing Technology Aiming to Cure Type 1 … – diaTribe Foundation Vertex and CRISPR Therapeutics Announce Licensing Agreement to Accelerate Development of Vertex’s Hypoimmune Cell Therapies for the Treatment of Type 1 Diabetes – Yahoo Finance